Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 85 results found. Search for [ Teva ]

Results 1 to 21 of 85
E Kumar Sharma
September 5, 2019
Even as smaller Indian companies are looking to grow their business in the US market, the larger focus is on leading pharma companies because the top 20 of them contribute 75 per cent to total pharma exports from India


Reuters
July 17, 2019
The U.S. Food and Drug Administration (FDA) said it found adulteration and \"significant violations\" of current good manufacturing practice (CGMP) regulations at Strides Pharma Sciences Ltd's plant in Puducherry in south India.


PTI
May 31, 2019



PTI
May 27, 2019



E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


PTI
May 14, 2019



BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: Breaking the nine consecutive falling streak, Benchmark Indices BSE Sensex and NSE Nifty closed in the green today, led by gains in PSU Banks, Pharma and Realty stocks.


PTI
New Delhi, May 14, 2019
Sun Pharma shares dived 9.39 per cent to close at Rs 396.85 on the BSE


PTI
May 13, 2019



PTI
February 20, 2019



E Kumar Sharma
New Delhi, February 14, 2019
Despite no big product launches in the US last year, Natco Pharma gained from its strategy of focussing on a few big products. It now hopes to build on this.


PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


E Kumar Sharma
New Delhi, November 26, 2018
Teva, Mylan, and even India's biggest, Sun Pharma, are opting out of products that aren't commercially viable.


E Kumar Sharma
New Delhi, November 21, 2018
Some of the leading Indian pharma companies are pitching in to cater to the markets that some of the big pharma companies are vacating as part of their product optimisation strategies.


E Kumar Sharma
October 26, 2018
The pharma major had posted a robust performance in the June quarter of FY19, largely aided by the launch in the US of gSuboxone, the generic version of the drug to deal opioid addiction.


BusinessToday.In
October 15, 2018
The Natco Pharma stock closed 5.57% or 37 points higher at 717.05 on the BSE. The stock has been gaining for the last two days and has risen 8.36% during the period. The stock hit an intra day high of 733.70 (8.02%) in trade today.


PB Jayakumar
New Delhi, June 8, 2018
The inspection team, which inspected the facilities between February 2-23, gave a 'voluntary action indicated' (VAI) remark to Sun's Halol plant in Gujarat.


E Kumar Sharma
May 24, 2018
Analysts read several things into it. First, they linked it to the fact that there was no negative shock especially in the US part of the business. There was a negative in the performance in Russia, an important contributor to the profitability of the company.


PAGES 1 OF 5  12345